Tharimmune (THAR) Form 4: 90,000 options at $3.075 granted

Tharimmune (THAR) insider Vincent LoPriore filed a Form 4 reporting a grant of 90,000 stock options at an exercise price of $3.075 on 11/03/2025.

Accepted by SEC EDGAR 11/05/2025 - 08:57 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Tharimmune (THAR) insider Vincent LoPriore filed a Form 4 reporting a grant of 90,000 stock options at an exercise price of $3.075 on 11/03/2025. The options are exercisable on 11/03/2025 and expire on 11/03/2035.

Following the transaction, LoPriore beneficially owned 190,000 derivative securities, held directly. He is listed as Executive Chairman, Director, and a 10% Owner.

Insider Trade Summary

Grant/Award: 90,000 shares

Grant/Award 1 txn

Insider LoPriore Vincent S

Role Executive Chairman

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	90,000	$0.00	$0.00

Holdings After Transaction: Stock Option — 190,000 contracts (Direct)

Holdings Before and After: Stock Option, 100,000 to 190,000 contracts (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did THAR report in this Form 4?

An insider, Vincent LoPriore, reported receiving 90,000 stock options at an exercise price of $3.075 on 11/03/2025.

What are the key dates for the reported THAR options?

The options are exercisable on 11/03/2025 and expire on 11/03/2035.

How many derivative securities does the insider own after the transaction?

LoPriore beneficially owned 190,000 derivative securities following the reported transaction.

What is the insider’s relationship to Tharimmune (THAR)?

He is an Executive Chairman, Director, and a 10% Owner.

What ownership form is indicated for the reported securities?

The ownership form is listed as Direct (D).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LoPriore Vincent S

(Last) (First) (Middle)

C/O THARIMMUNE, INC.

34 SHREWSBURY AVE.

(Street)

RED BANK NJ 07701

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Tharimmune, Inc. [ THAR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$3.075	11/03/2025		A		90,000		11/03/2025	11/03/2035	Common Stock	90,000	$0	190,000	D

Explanation of Responses:

	/s/ Vincent LoPriore	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.